Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma <scp>HDL</scp> levels in chronic kidney disease

Abstract

Acquired LCAT deficiency is a major cause of low plasma HDL levels in patients with CKD, thus LCAT is an attractive target for therapeutic intervention to reverse dyslipidaemia, and possibly lower the cardiovascular disease risk in these patients.